Omar Khalil

Director/Board Member at

Solu Therapeutics

Health Technology

Commercial Services

Consumer Services

Profile

Omar Khalil is currently Managing Director at SHVMS, LLC since 2024.
Mr. Khalil is Director at Geneos Therapeutics, Inc. since 2023.
Mr. Khalil is Director at Kestrel Therapeutics, Inc. since 2022.
Mr. Khalil is Director at Solu Therapeutics, Inc. since 2023.
Mr. Khalil is Board Member at MycRX since 2021.
Former roles include Vice President & US Hospital Products at Baxter International, Inc. from 2015 to 2017, Vice President & General Manager at Kaleo, Inc. from 2017 to 2020, and Principal at McKinsey & Co., Inc. Education includes undergraduate and graduate degrees from the University of Michigan.

Omar Khalil active positions

Companies	Position	Start
SHVMS, LLC SHVMS, LLC Investment ManagersFinance Sante Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical technologies, biotechnology, healthcare services and healthcare IT. It provides financing for seed and early-stage capital requirements.	Private Equity Investor	01/01/2020
Kestrel Therapeutics, Inc. Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology development company	Director/Board Member	01/01/2022
Solu Therapeutics Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity	Director/Board Member	01/01/2023
MycRx MycRx Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops small molecule inhibitors of the Myc oncoprotein	Director/Board Member	01/01/2021
Geneos Therapeutics, Inc. Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies	Director/Board Member	01/01/2023

All active positions of Omar Khalil

Former positions of Omar Khalil

Companies	Position	End
Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug or device combination products	Private Equity Investor	01/01/2020
BAXTER INTERNATIONAL INC.	Corporate Officer/Principal	01/01/2017
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Corporate Officer/Principal	-

See the detail of Omar Khalil's experience

Training of Omar Khalil

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Omar Khalil's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Baxter International, Inc. Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services	Health Technology
Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug or device combination products	Health Technology
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SHVMS, LLC SHVMS, LLC Investment ManagersFinance Sante Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical technologies, biotechnology, healthcare services and healthcare IT. It provides financing for seed and early-stage capital requirements.	Finance
Geneos Therapeutics, Inc. Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies	Health Technology
Kestrel Therapeutics, Inc. Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology development company	Commercial Services
MycRx MycRx Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops small molecule inhibitors of the Myc oncoprotein	Commercial Services
Solu Therapeutics Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity	Health Technology